Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Celgene Corp
(NQ:
CELG
)
122.18
USD
-1.46 (-1.18%)
Streaming Delayed Price
/ Updated:
2:14 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Celgene Corp
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
RBCC: Could Stem Cells Be Key to Promising Autism Therapy?
October 16, 2012
from
Business Wire News Releases
FDA Approves ABRAXANE® for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
October 12, 2012
from
Business Wire News Releases
RBCC: Nobel Prize Could Bring Big Investments in Stem Cell Research
October 11, 2012
from
Business Wire News Releases
Celgene Corporation to Announce Third Quarter 2012 Results on October 25, 2012
October 08, 2012
from
Business Wire News Releases
RBCC: NASA Bioreactor Could Speed Parkinson’s Research
October 04, 2012
from
Business Wire News Releases
Celgene Corporation Provides Update on FDA Advisory Committee for Pomalidomide
October 03, 2012
from
Business Wire News Releases
VentiRx Pharmaceuticals Announces Exclusive, Strategic Collaboration for Development of Novel TLR8 Agonist VTX-2337 with Celgene Corporation
October 03, 2012
from
PR Newswire
ABRAXANE cumple con el objetivo primario de supervivencia sin evolución en un ensayo clínico de Fase III sobre melanomas metastásicos sin quimioterapia previa
October 02, 2012
from
Business Wire Spanish
ABRAXANE Meets Primary Endpoint of Progression-Free Survival in Phase III Chemotherapy-Naïve Metastatic Melanoma Study
October 02, 2012
from
Business Wire News Releases
RBCC: Stem Cell Market Poised for Billion-Dollar Growth
September 27, 2012
from
Business Wire News Releases
Celgene Corporation Announces Pomalidomide Will Be Reviewed at FDA Advisory Committee
September 19, 2012
from
Business Wire News Releases
RBCC Initiates Talks to Acquire License for NASA Bioreactor Technology
September 19, 2012
from
Business Wire News Releases
RBCC Explores NASA Technology in Stem Cell Search
September 18, 2012
from
Business Wire News Releases
RBCC Expands Cell Culturing Focus to Include Adult Stem Cells
September 17, 2012
from
Business Wire News Releases
Equity Research on Celgene Corp. and Gilead Sciences Inc. -- Positive Tests and FDA Approvals Buoy Biotechnology Companies
September 07, 2012
from
Marketwired News Releases
Critical Alerts For ConocoPhillips, Newmont Mining, Celgene, Whirlpool, and Spreadtrum Communications Released By InvestorsObserver
September 04, 2012
from
PR Newswire
Codexis Appoints David O’Toole as Chief Financial Officer
September 04, 2012
from
Business Wire News Releases
Celgene Corporation to Present at Investor Conferences in September
August 27, 2012
from
Business Wire News Releases
Hot Stocks: NetApp, Idenix, Juniper Networks, Home Depot, Melco Crown Entertainment, and Celgene
August 17, 2012
from
PR Newswire
Study of Vacc-4x Combined With Celgene's Revlimid(R) (lenalidomide) in HIV Patients With Impaired Immune System Approved to Begin
August 13, 2012
from
Marketwired News Releases
Celgene Prices $1.5 Billion of Senior Unsecured Notes
August 07, 2012
from
Business Wire News Releases
Celgene Announces Offering of Senior Unsecured Notes
August 06, 2012
from
Business Wire News Releases
Critical Trade Alerts For Goldman Sachs, Costco, Celgene, TripAdvisor, and Westport Innovations Released By InvestorsObserver
July 27, 2012
from
PR Newswire
Celgene Reports Second Quarter 2012 Operating and Financial Results
July 26, 2012
from
Business Wire News Releases
Celgene Corporation to Announce Second Quarter 2012 Results on July 26, 2012
July 16, 2012
from
Business Wire News Releases
Biotech Companies -- Led by Amgen and Celgene -- Increase R&D Spending in 2011
July 05, 2012
Five Star Equities Provides Stock Research on Amgen and Celgene
Read More
from
Marketwired News Releases
Report for Most Active Stocks: Citigroup, Celgene, Seagate, Morgan Stanley, ConocoPhillips, and Metlife
June 22, 2012
from
PR Newswire
Critical Alerts For Home Depot, JC Penney, Express Scripts, Celgene, and Allscripts Released By InvestorsObserver
June 15, 2012
from
PR Newswire
Celgene Announces Additional $2.5 Billion Share Repurchase Program
June 13, 2012
from
Business Wire News Releases
Where Opportunity is Found - Research & Analysis on Celgene Corporation and TW Telecom Inc
June 07, 2012
from
Marketwired News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here